gb226
Showing 1 - 1 of 1
Metastatic NSCLC Trial in Shanghai (GB226, Fruquintinib)
Recruiting
- Metastatic Non-small Cell Lung Cancer
- GB226
- Fruquintinib
-
Shanghai, Shanghai, ChinaShanghai chest hospital
Mar 2, 2021